News

Nader Pourhassan, PHD, president and chief executive officer of CytoDyn, the biotechnology company that acquired PRO 140, offers insight into the antibody as treatment for HIV.

Due to concerns that the use of PrEP might hinder clinicians from detecting HIV in infected individuals or lead to the development of resistant strains of HIV, scientists studied how PrEP affects seroconversion after HIV is acquired.

A phase 2a clinical trial has found the dapivirine vaginal ring to be a safe and acceptable means for HIV prevention in adolescents, who showed notably high adherence when using the ring.

Recent research coming in from Weill Cornell Medicine/Memorial Sloan Kettering suggests that a possible cure for Zika virus may be hiding in plain sight.

The NIH has released the findings of the first of 2 early-stage clinical trials on assessing the safety and effectiveness of HIV candidate vaccinations that support additional development of vaccines.

As the IAS Conference on HIV Science wraps up this week, this Public Health Watch report takes a closer look at the challenges that remain when it comes to treating HIV.

Phase 2 study finds that the use of daily oral Truvada as a means of HIV prevention is safe and acceptable.

Scientists make an interesting connection between bats and detecting undiscovered disease.

In a time of growing population and dependence on food, what methods are the best to use for food safety detection?

A recent study finds that the majority of HIV-infected transgender women are anxious about taking ART and feminizing hormone therapy simultaneously due to hazardous drug interactions.

Universal health coverage comes at a price but can countries afford it?

WHO and IAS come together to create the first-ever global research prioritization agendas at the 9th IAS Conference on HIV Science in Paris, France.

Study finds that hepatitis C patients who had reached sustained virologic response using direct-acting antiviral drugs show a considerably reduced risk of the most common type of liver cancer.

A recent WHO news release reports that infant immunization rates continue to fall short of the global immunization target of 90%.

The results of a phase 2 trial for a 2-drug regimen of long-acting cabotegravir and rilpivirine and a 3-drug regimen in patient with HIV showed comparable viral suppression rates at 96 weeks.

Researchers from Dartmouth College’s Geisel School of Medicine have found that pregnant women with a history of HSV-1 maintain active antibodies against the virus that can be passed on to their newborns.

A team of researchers assesses the impact of “Rory’s Regulations,” a set of mandates for hospitals in New York State that establish protocols for the diagnosis and treatment of sepsis.

The World Health Organization (WHO) recently sent out a global alert warning of the growing threat of resistance to HIV drugs.

A systematic review analyzes the opportunity to provide coordinated care for HIV and noncommunicable conditions.

Women with HIV are at higher risk of having potentially cancer-causing HPV in their anal canals, raising questions about how best to screen this population.

The polio vaccine (mOPV2) has arrived in Deir Ez-Zor governate, as health officials are working on the implementation of immunization campaigns to stop transmission.

Outbreaks of measles have resulted in over 14,000 infections and the loss of 35 lives across Europe since January 2016.

Research coming in from Fernandes Figueira-Fundação Oswaldo Cruz finds that when it comes to diagnosing Zika virus infection in newborns, the eyes may have it.

Doctor Without Borders is criticizing countries and government agencies alike for seemingly downplaying the impact of tuberculosis around the world.

Although the yellow fever outbreak that has affected several Latin American countries has eased since the end of summer, health officials say new cases are still springing up in some areas.

The new Senate healthcare bill released last week has died on the vine, even before it was formally put forward for deliberation and vote.

Ebola virus tracking and mechanisms to detect threats to our national food supply are highlighted.